Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116107903 | 11610790 | 3 | F | 20160629 | 20151008 | 20160706 | EXP | ZA-ROCHE-1642118 | ROCHE | 0.00 | M | Y | 0.00000 | 20160707 | MD | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116107903 | 11610790 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 5 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 7 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 8 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 | |||||||||
| 116107903 | 11610790 | 9 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | S0077 ;/JUL/2017,S0087; NOV/2017,S | 125156 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116107903 | 11610790 | 1 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116107903 | 11610790 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116107903 | 11610790 | Retinal oedema | |
| 116107903 | 11610790 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116107903 | 11610790 | 1 | 20141211 | 0 | ||
| 116107903 | 11610790 | 2 | 20150115 | 0 | ||
| 116107903 | 11610790 | 3 | 20150219 | 20150219 | 0 | |
| 116107903 | 11610790 | 4 | 20150923 | 0 | ||
| 116107903 | 11610790 | 5 | 20151027 | 0 | ||
| 116107903 | 11610790 | 6 | 20151201 | 0 | ||
| 116107903 | 11610790 | 7 | 20160219 | 0 | ||
| 116107903 | 11610790 | 8 | 20160419 | 0 | ||
| 116107903 | 11610790 | 9 | 20160614 | 0 |